Nachrichten zur China Biologic Products Holdings Aktie

China Biologic Products Inc (CBPO) Q1 2019 Earnings Call Transcript

CBPO earnings call for the period ending March 31, 2019....…

China Biologic Products Holdings, Inc. (CBPO) Management on Q1 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

China Biologic Products (CBPO) Tops Q1 Earnings and Revenue Estimates

China Biologic Products (CBPO) delivered earnings and revenue surprises of 12.12% and 8.61%, respectively, for the quarter ended March 2019.…

Earnings Preview: China Biologic Products (CBPO) Q1 Earnings Expected to Decline

China Biologic Products (CBPO) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…

Analysts Estimate China Biologic Products (CBPO) to Report a Decline in Earnings: What to Look Out for

China Biologic Products (CBPO) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…

China Biologic Products Inc (CBPO) Q4 2018 Earnings Conference Call Transcript

CBPO earnings call for the period ending December 31, 2018....…

China Biologic Products, Inc. (CBPO) CEO Bing Li on Q4 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results

BEIJING , Feb. 25, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China…

China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman

BEIJING , Dec. 14, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO ) (" …

China Biologic Products, Inc. (CBPO) CEO Bing Light on Q3 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Final trades: Starbucks, Emerging Markets, SunTrust & China Biologic Products

The "Halftime Report" traders give their top stocks to watch for the second half....…

Heres Why China Biologic Products Stock Dropped Today

After receiving two buyout offers this summer, the company forged its own path forward -- one that stuffs the balance…

UPDATE 2-China Biologic rejects $3.9 bln bid from former CEO

China Biologic Products Holdings Inc rejected a $3.9 billion offer from a consortium led by its former chief executive on Friday and…

UPDATE 1-China Biologic rejects former CEO-led consortiums offer

China Biologic Products Holdings Inc said on Friday it had rejected an offer from a consortium led by its former chief executive…

China Biologic rejects former CEO-led consortiums offer

China Biologic Products Holdings Inc said on Friday it had rejected an offer from a consortium led by its former chief executive…

China Biologic Products (CBPO) Looks Good: Stock Adds 8.7% in Session

China Biologic Products (CBPO) saw a big move last session, as its shares jumped nearly 9% on the day, amid…

Übernahmeschlacht um China Biologic Products - das müssen Sie wissen

Der Verfall des Renminbi hat sich auch im AKTIONÄR China Biotech Index bemerkbar gemacht. Zwei Drittel der Indexmitglieder notieren schließlich…

Heres Why China Biologic Products Stock Is Soaring Today

The blood plasma specialist has received a second buyout offer....…

CORRECTED-UPDATE 1-China Biologic gets $3.9 bln offer from former CEO-led consortium

China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms led by the…

CORRECTED-China Biologic gets $3.9 bln offer from former CEO-led consortium

China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium that included companys former chief executive,…

UPDATE 1-China Biologic gets $3.9 bln offer from former CEO-led consortium

China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms led by the…

China Biologic gets $3.9 bln offer from former CEO-led consortium

China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium that included companys former chief executive,…

Consortium seeks to acquire China Biologic Products for $3.9 billion in cash

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

China Biologic Products, Inc. (CBPO) Q2 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

China Biologic Products to Report Second Quarter 2018 Financial Results

BEIJING , July 27, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China…

Ping An Said to Mull Rival Takeover Offer for China Biologic

Ping An Insurance (Group) Co., Chinas largest insurer by market value, is considering a rival offer for plasma treatment provider…

CITIC Capital Proposes To Acquire China Biologic Products Holdings For $3.65B

A unit of Chinese investment firm CITIC Capital Holdings Ltd. has offered to buy NASDAQ-listed biotech firm China Biologic Products…

WeissLaw LLP Investigates China Biologic Products Holdings, Inc.

NEW YORK, June 18, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of…

Heres Why China Biologic Products Holdings Inc. Soared as Much as 25.8% Today

The Chinese plasma manufacturer might be acquired for $110 per share....…

UPDATE 1-CITIC Capital offers to buy China Biologic for $110 per share

June 18 (Reuters) - A unit of Chinese investment firm CITIC Capital Holdings Ltd said on Monday it has offered to…

Investment firm CITIC Capital offers to buy China Biologic Products

June 18 (Reuters) - A unit of Chinese investment firm CITIC Capital Holdings Ltd has offered to buy U.S.-listed biotech firm China…

China Biologic Products (CBPO) CEO David Gao on Q1 2018 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

BRIEF-China Biologic Says Excluding Financial Results Of Tianxinfu, Q1 Sales To Grow About 2% In RMB

* CHINA BIOLOGIC PRODUCTS HOLDINGS - EXCLUDING FINANCIAL RESULTS OF TIANXINFU, TOTAL SALES IN Q1 OF 2018 EXPECTED TO GROW ABOUT 2%…

China Biologic Products (CBPO) CEO David Gao on Q4 2017 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

China Biologic Products (CBPO) CEO David Gao on Q3 2017 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

FRA:New Instruments available on XETRA - 25.10.2017-002

The following instruments on XETRA do have their first trading day 25.10.2017 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag…

China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition

BEIJING, Oct. 13, 2017 /PRNewswire/ -- China Biologic Products Holding, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading…